Exosens announces the success of its first employee share offering, "ExoShare"
PRESS RELEASE
13th NOVEMBER 2025
Exosens announces the outstanding success of ExoShare, its first employee share ownership plan, marked by strong participation from teams across all countries where the Group operates. This momentum confirms employees’ confidence in the company’s strategy and their desire to take part, as shareholders, in its future.
On 15 September 2025, Exosens launched “ExoShare,” its first employee share ownership plan, across the entire Group (France and International). By enabling everyone to invest in the company, the plan strengthens day-to-day engagement, supports talent retention, and enhances the employer brand—both in France and worldwide.
At the end of the subscription period, 53% of eligible employees—more than one in two—have chosen to invest in the Group’s future by becoming Exosens shareholders on preferential terms.
Jérôme Cerisier, Exosens CEO commented: “ExoShare, Exosens’ employee share ownership plan, was launched for the first time this year since our stock-market listing. It is an exceptional success worldwide, with 53% of employees across 10 countries taking part in the program. It reflects our people’s confidence in Exosens’ future, and it also illustrates the team spirit, passion and entrepreneurial mindset that drive all our colleagues. This commitment helps Exosens grow—and helps all of us grow. I thank them personally and warmly for this collective success.”
As part of this transaction, Exosens was supported by Amundi, the law firm Mayer Brown and communication agency Butterfly. 154,197 new shares will be issued on 13 November 2025. They will be fully fungible with Exosens shares already admitted to trading on Euronext Paris. Following this issuance, employee ownership of the company’s share capital, via the “ExoShare” FCPE (employee mutual fund) and in registered form, amounts to 0.33%, based on the company’s share capital as of 13 November 2025.
Media contacts for Exosens
Brunswick group – exosens@brunswickgroup.com
Laetitia Quignon + 33 6 83 17 89 13